Mather Group
CRL icon

Mather Group’s Charles River Laboratories CRL Stock Holding History

Mather Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$49.6K Buy
168
+90
+115% +$23.7K ﹤0.01% 1164
2026
Q2 		$17.7K Buy
78
+27
+53% +$4.81K ﹤0.01% 1358
2026
Q1 		$8.8K Buy
+51
New +$9.46K ﹤0.01% 1477
2025
Q4 		– Sell
-124
Closed -$19.4K – 857
2025
Q3 		$19.4K Buy
+124
New +$19.7K ﹤0.01% 1127
2025
Q2 		– Sell
-667
Closed -$100K – 845
2025
Q1 		$100K Buy
667
+309
+86% +$51.8K ﹤0.01% 749
2024
Q4 		$66.1K Sell
358
-91
-20% -$17.5K ﹤0.01% 821
2024
Q3 		$88.4K Buy
449
+92
+26% +$19.1K ﹤0.01% 761
2024
Q2 		$96.7K Sell
357
-14
-4% -$3.17K ﹤0.01% 821
2024
Q1 		$87.7K Buy
+371
New +$88.6K ﹤0.01% 742

Other funds holding CRL

Cooke & Bieler
Cooke & Bieler Philadelphia, Pennsylvania $6.36B AUM 0.55% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Confluence Investment Management
Confluence Investment Management St. Louis, Missouri $5.97B AUM 5.11% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Sendero Wealth Management
Sendero Wealth Management San Antonio, Texas $1B AUM 21.35% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
PensionDanmark
PensionDanmark Copenhagen O, Denmark $12.3B AUM 33.99% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return
Cardinal Capital Management Inc (North Carolina)
Cardinal Capital Management Inc (North Carolina) Raleigh, North Carolina $861M AUM 27.19% 1-Year Est. Return

Mather Group's CRL Position: Q3 2026 in Review

Mather Group increased its Charles River Laboratories (CRL) stake by 115% in Q3 2026, buying an estimated $23.7K and bringing the position to 168 shares worth $49.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1164.

Mather Group first reported a position in CRL in Q1 2024 and has held it in 9 quarters since. The position peaked at $100K in Q1 2025. 82 funds tracked by Wall St. Rank hold CRL as of Q3 2026.

  • Mather Group held 168 shares of Charles River Laboratories worth $49.6K as of Q3 2026.
  • Mather Group bought 90 Charles River Laboratories shares in Q3 2026, an estimated $23.7K.
  • Charles River Laboratories made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1164 holding.
  • Mather Group first reported a position in Charles River Laboratories in Q1 2024 and has held it in 9 quarters since.
  • Mather Group's Charles River Laboratories position peaked at $100K in Q1 2025.
  • 82 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.